JMNAX | VMNIX | JMNAX / VMNIX | |
Total Expense Ratio | 2.74 | 1.34 | 204% |
Annual Report Gross Expense Ratio | 2.87 | 1.34 | 214% |
Fund Existence | 24 years | 27 years | - |
Gain YTD | 3.384 | 5.580 | 61% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 396M | 376M | 105% |
Annual Yield % from dividends | 2.33 | 5.49 | 42% |
Returns for 1 year | 5.28 | 1.98 | 267% |
Returns for 3 years | 29.12 | 28.86 | 101% |
Returns for 5 years | 21.55 | 59.27 | 36% |
Returns for 10 years | 8.26 | 27.78 | 30% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIS | 13.71 | 0.25 | +1.83% |
ProShares UltraShort Nasdaq Biotech | |||
WLTG | 33.73 | 0.11 | +0.33% |
WealthTrust DBS Long Term Growth ETF | |||
SEPW | 31.08 | 0.03 | +0.10% |
AllianzIM U.S. Large Cp Buffer20 Sep ETF | |||
RWO | 45.73 | 0.01 | +0.02% |
SPDR® Dow Jones® Global Real Estate ETF | |||
OMAH | 19.44 | -0.04 | -0.21% |
Vistashares Target 15 Berkshire Select Income ETF |